Page last updated: 2024-09-03

emeriamine and Diabetes Mellitus, Type 2

emeriamine has been researched along with Diabetes Mellitus, Type 2 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arduini, A; Ceccarelli, SM; Chomienne, O; Gubler, M1
Cabri, W; Carminati, P; Conti, R; Dell'Uomo, N; Gallo, G; Giannessi, F; Mastrofrancesco, L; Ricciolini, R; Tassoni, E; Vincenti, S1

Other Studies

2 other study(ies) available for emeriamine and Diabetes Mellitus, Type 2

ArticleYear
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
    Journal of medicinal chemistry, 2011, May-12, Volume: 54, Issue:9

    Topics: Animals; Carnitine; Carnitine O-Palmitoyltransferase; Catalytic Domain; Diabetes Mellitus, Type 2; Energy Metabolism; Enzyme Activators; Ethylene Oxide; Heart Failure; Humans; Insulin Resistance; Isoenzymes; Lipid Metabolism; Myocardial Ischemia; Organ Specificity; Protein Conformation; Sequence Homology, Amino Acid; Stereoisomerism

2011
Aminocarnitine ureidic derivatives as inhibitors of carnitine palmitoyltransferase I.
    ChemMedChem, 2010, May-03, Volume: 5, Issue:5

    Topics: Animals; Betaine; Binding Sites; Carnitine; Carnitine O-Palmitoyltransferase; Computer Simulation; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Hypoglycemic Agents; Mice; Rats

2010